PCVX
Vaxcyte, Inc.
Vaxcyte, Inc. (PCVX) has 5 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 26, 2026.
Insiders have net sold $3.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Grant E. Pickering
- Employees:414
- HQ:San Carlos, CA, US
- IPO:2020-06-12
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$8.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CHIEF EXECUTIVE OFFICER | Sale | 24,237 | $1.3M | Jun 26 | SEC ↗ | |
PICKERING GRANTFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 23,461 | $1.2M | Jun 19 | SEC ↗ |
GUGGENHIME ANDREWFirst filing | PRESIDENT AND CFO | Sale | 10,000 | $530K | Jun 19 | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 2,250 | $111K | Jun 3 | SEC ↗ | |
Wassil JimFirst filing | CHIEF OPERATING OFFICER | Sale | 2,250 | $128K | May 1 | SEC ↗ |
Congress trading PCVX
See timeline →- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-12
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
Vaxcyte, Inc. is in the Healthcare sector.